RESULTS: Air blast and SSCDS applications were compared using water sensitive paper, bioassays, and pest damage assessments. Pest management and coverage were compared using application volumes of 700 and 795 L ha-1 , respectively. In 2013, adaxial coverage measurements showed no difference between the treatments, but air blast sprayers had higher coverage levels on the abaxial surfaces. There were no significant differences in coverage in 2014. Bioassays using Choristoneura rosaceana fed on leaf discs treated by the SSCDS displayed 95.8% mortality in 2013 and 94.2% mortality in 2014, and air blast treated larval mortality was 95% in 2013 and 100% in 2014. Damage evaluations in both years generally showed no significant differences between the air blast plots and the SSCDS plots, but significant differences between the treated plots and untreated control.
CONCLUSIONS: The prototype SSCDS was an effective pest management tool in high density apples, and offered a number of advantages over an air blast. Further engineering and research into coverage optimization would offer producers a novel tool for foliar agrochemical applications. © 2019 Society of Chemical Industry.
Methods: Participants (GP-allergic with AR, 330; non-atopic, 29; other allergies, 54) were recruited in subtropical: Queensland, and temperate: New South Wales, Western and South Australia, regions. Clinical history, skin prick test (SPT), total and specific IgE to GP and purified allergens (ImmunoCAP) were evaluated. Cross-inhibition of sIgE with Pas n 1, Cyn d 1 and Lol p 1 by GP extracts was investigated.
Results: Queensland participants showed higher sensitisation to P. notatum and C. dactylon than L. perenne GP. sIgE was higher to Pas n 1 and Cyn d 1, and sIgE to Pas n 1 and Cyn d 1 was inhibited more by Panicoideae and Chloridoideae, respectively, than Pooideae GP. Conversely, participants from temperate regions showed highest sensitisation levels to L. perenne GP and Lol p 1, and sIgE to Lol p 1 was inhibited more by Pooideae than other GP.
Conclusion: Levels and patterns of sensitisation to subtropical and temperate GP in AR patients depended on biogeography. Knowledge of the specificity of sensitisation to local allergens is important for optimal diagnosis and choice of allergen-specific immunotherapy to maximise benefit.
METHODS: The European Academy of Neurology (EAN) task force (TF) met nine times between November 2021 and June 2023. During the 2023 EAN annual meeting, attendees were asked to answer five questions concerning the future of GN. The document was sent for suggestions and eventually approval to the board and the presidents of the 47 national societies of the EAN.
RESULTS: The TF first identified four relevant current and future challenges related to GN: (i) definition, (ii) practice, (iii) education, and (iv) research. The TF then identified seven initiatives to further develop GN at both the academic and community level. Finally, the TF formulated 16 recommendations to promote GN in the future.
CONCLUSIONS: GN will remain essential in the coming decades to provide rapid, accessible, and comprehensive management of patients with ND that is affordable and cost-effective. There is also a need for research, education, and other initiatives aiming to facilitate improved working conditions, recognition, and prestige for those pursuing a career in GN.